Vimarsana
Biggest News Aggregation in the World

Page 2 - Thomas Equels News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Thomas Equels. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Thomas Equels Today - Breaking & Trending Today

AIM ImmunoTech Inc. (AMEX:AIM) Q1 2023 Earnings Call Transcript - Vimarsana News

AIM ImmunoTech Inc. (AMEX:AIM) Q1 2023 Earnings Call Transcript

Operator: Hello, and welcome to the AIM ImmunoTech Quarterly Update Conference Call and Webcast. As a brief reminder, all participants are currently in a listen-only mode.

AIM ImmunoTech Inc. (AMEX:AIM) Q4 2022 Earnings Call Transcript - Vimarsana News

AIM ImmunoTech Inc. (AMEX:AIM) Q4 2022 Earnings Call Transcript

Operator: Hello, and welcome to the AIM ImmunoTech Inaugural Fiscal Year 2022 Update Conference Call and Webcast. As a brief reminder, all participants are currently in a listen-only mode.

AIM ImmunoTech Inc says study partner Roswell Park has commenced patient enrollment in Ampligen and Primary PD-1/PD-L1 resistant melanoma phase 2 trial - Vimarsana News

AIM ImmunoTech Inc says study partner Roswell Park has commenced patient enrollment in Ampligen and Primary PD-1/PD-L1 resistant melanoma phase 2 trial

The study will evaluate type-1 polarized dendritic cell (αDC1) vaccine in combination with tumor-selective chemokine modulation comprised of...

AIM ImmunoTech outlines Phase II study plans for long Covid fatigue - Vimarsana News

AIM ImmunoTech outlines Phase II study plans for long Covid fatigue

AIM ImmunoTech leadership offers new details on a potential Phase II trial of Ampligen in long Covid patients with chronic fatigue.

AIM ImmunoTech reports positive Phase III data of Ampligen for long Covid - Vimarsana News

AIM ImmunoTech reports positive Phase III data of Ampligen for long Covid

AIM ImmunoTech has reported positive initial pilot study data from its Phase III trial of an investigational drug, Ampligen, for long Covid.